Skip to main content
Top
Published in: Annals of Intensive Care 1/2024

Open Access 01-12-2024 | Cardiogenic Shock | Research

Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI

Authors: Shih-Chieh Chien, Cheng-An Wang, Hung-Yi Liu, Chao-Feng Lin, Chun-Yao Huang, Li-Nien Chien

Published in: Annals of Intensive Care | Issue 1/2024

Login to get access

Abstract

Background

Current data on post-discharge mortality and rehospitalization is still insufficient among in-hospital survivors of cardiogenic shock (CS), including acute myocardial infarction (AMI) and non-AMI survivors.

Methods

Patients with CS who survived after hospital discharge were selected from the Taiwan National Health Insurance Research Database. Each patient was followed up at 3-year intervals. Mortality and rehospitalization were analyzed using Kaplan-Meier curves and Cox regression models.

Results

There were 16,582 eligible patients. Of these, 42.4% and 57.6% were AMI-CS and non-AMI-CS survivors, respectively. The overall mortality and rehospitalization rates were considerably high, with reports of 7.0% and 22.1% at 30 days, 24.5% and 58.2% at 1 year, and 38.9% and 73.0% at 3 years, respectively, among in-hospital CS survivors. Cardiovascular (CV) problems caused approximately 40% mortality and 60% rehospitalization. Overall, the non-AMI-CS group had a higher mortality burden than the AMI-CS group owing to older age and a higher prevalence of comorbidities. In multivariable models, the non-AMI-CS group exhibited a lower risk of all-cause mortality (adjusted hazard ratio [aHR] 0.69, 95% confidence interval [CI] 0.60 to 0.78) and CV mortality (aHR 0.65, 95% CI 0.54 to 0.78) compared to the AMI-CS group. However, these risks diminished and even reversed after one year (aHR 1.13, 95% CI 1.03 to 1.25 for all-cause mortality; aHR 1.27, 95% CI 1.09 to 1.49 for CV mortality).This reversal was not observed in all-cause and CV rehospitalization. For rehospitalization, AMI-CS was associated with the risk of CV rehospitalization in the entire observation period (aHR:0.80, 95% CI:0.76–0.84).

Conclusions

In-hospital AMI-CS survivors had an increased risk of CV rehospitalization and 30-day mortality, whereas those with non-AMI-CS had a greater mortality risk after 1-year follow-up.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, et al. Twenty-year trends in the incidence and outcome of cardiogenic shock in AMIS Plus Registry. Circ Cardiovasc Interv. 2019;12(4):e007293.CrossRefPubMed Hunziker L, Radovanovic D, Jeger R, Pedrazzini G, Cuculi F, Urban P, et al. Twenty-year trends in the incidence and outcome of cardiogenic shock in AMIS Plus Registry. Circ Cardiovasc Interv. 2019;12(4):e007293.CrossRefPubMed
2.
3.
go back to reference Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, et al. Fifteen-year trends in incidence of cardiogenic shock hospitalization and In-Hospital mortality in the United States. J Am Heart Assoc. 2021;10(15):e021061.CrossRefPubMedPubMedCentral Osman M, Syed M, Patibandla S, Sulaiman S, Kheiri B, Shah MK, et al. Fifteen-year trends in incidence of cardiogenic shock hospitalization and In-Hospital mortality in the United States. J Am Heart Assoc. 2021;10(15):e021061.CrossRefPubMedPubMedCentral
4.
go back to reference Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, von Zur Muehlen C, et al. Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007-2017-insights from a national registry. Clin Res Cardiol. 2021;110(9):1421–30.CrossRefPubMed Lang CN, Kaier K, Zotzmann V, Stachon P, Pottgiesser T, von Zur Muehlen C, et al. Cardiogenic shock: incidence, survival and mechanical circulatory support usage 2007-2017-insights from a national registry. Clin Res Cardiol. 2021;110(9):1421–30.CrossRefPubMed
5.
go back to reference Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, et al. Post-hospital outcomes of patients with Acute Myocardial Infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67(7):739–47.CrossRefPubMed Shah RU, de Lemos JA, Wang TY, Chen AY, Thomas L, Sutton NR, et al. Post-hospital outcomes of patients with Acute Myocardial Infarction with cardiogenic shock: findings from the NCDR. J Am Coll Cardiol. 2016;67(7):739–47.CrossRefPubMed
6.
go back to reference Aissaoui N, Puymirat E, Simon T, Bonnefoy-Cudraz E, Angoulvant D, Schiele F, et al. Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) Registry. Crit Care. 2014;18(5):516.CrossRefPubMedPubMedCentral Aissaoui N, Puymirat E, Simon T, Bonnefoy-Cudraz E, Angoulvant D, Schiele F, et al. Long-term outcome in early survivors of cardiogenic shock at the acute stage of myocardial infarction: a landmark analysis from the French registry of Acute ST-elevation and non-ST-elevation myocardial infarction (FAST-MI) Registry. Crit Care. 2014;18(5):516.CrossRefPubMedPubMedCentral
7.
go back to reference Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, et al. Causes and predictors of 30-Day readmission in patients with Acute myocardial infarction and cardiogenic shock. Circ Heart Fail. 2018;11(4):e004310.CrossRefPubMed Shah M, Patil S, Patel B, Agarwal M, Davila CD, Garg L, et al. Causes and predictors of 30-Day readmission in patients with Acute myocardial infarction and cardiogenic shock. Circ Heart Fail. 2018;11(4):e004310.CrossRefPubMed
8.
go back to reference Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117(5):686–97.CrossRefPubMed Reynolds HR, Hochman JS. Cardiogenic shock: current concepts and improving outcomes. Circulation. 2008;117(5):686–97.CrossRefPubMed
9.
go back to reference Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–9.CrossRefPubMed Harjola VP, Lassus J, Sionis A, Køber L, Tarvasmäki T, Spinar J, et al. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail. 2015;17(5):501–9.CrossRefPubMed
11.
go back to reference Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018;107(4):287–303.CrossRefPubMed Shah M, Patnaik S, Patel B, Ram P, Garg L, Agarwal M, et al. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol. 2018;107(4):287–303.CrossRefPubMed
12.
go back to reference Hsing AW, Ioannidis JP. Nationwide Population Science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527–9.CrossRefPubMed Hsing AW, Ioannidis JP. Nationwide Population Science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med. 2015;175(9):1527–9.CrossRefPubMed
13.
go back to reference Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, et al. Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349–58.CrossRefPubMedPubMedCentral Hsieh CY, Su CC, Shao SC, Sung SF, Lin SJ, Kao Yang YH, et al. Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol. 2019;11:349–58.CrossRefPubMedPubMedCentral
15.
go back to reference Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.CrossRefPubMed Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.CrossRefPubMed
16.
go back to reference Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and Comprehensive Approach to the management of cardiogenic shock. JACC Heart Fail. 2020;8(11):879–91.CrossRefPubMedPubMedCentral Tehrani BN, Truesdell AG, Psotka MA, Rosner C, Singh R, Sinha SS, et al. A standardized and Comprehensive Approach to the management of cardiogenic shock. JACC Heart Fail. 2020;8(11):879–91.CrossRefPubMedPubMedCentral
17.
go back to reference van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of cardiogenic shock: a Scientific Statement from the American Heart Association. Circulation. 2017;136(16):e232–68.PubMed van Diepen S, Katz JN, Albert NM, Henry TD, Jacobs AK, Kapur NK, et al. Contemporary Management of cardiogenic shock: a Scientific Statement from the American Heart Association. Circulation. 2017;136(16):e232–68.PubMed
18.
go back to reference Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454–61.CrossRefPubMed Basir MB, Schreiber T, Dixon S, Alaswad K, Patel K, Almany S, et al. Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: the Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv. 2018;91(3):454–61.CrossRefPubMed
19.
go back to reference Feng Z, Fonarow GC, Ziaeian B. Palliative care services in patients admitted with cardiogenic shock in the United States: frequency and predictors of 30-day readmission. J Card Fail. 2021;27(5):560–720.CrossRefPubMedPubMedCentral Feng Z, Fonarow GC, Ziaeian B. Palliative care services in patients admitted with cardiogenic shock in the United States: frequency and predictors of 30-day readmission. J Card Fail. 2021;27(5):560–720.CrossRefPubMedPubMedCentral
20.
go back to reference Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, et al. Twenty Year trends and Sex differences in young adults hospitalized with Acute myocardial infarction. Circulation. 2019;139(8):1047–56.CrossRefPubMedPubMedCentral Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, et al. Twenty Year trends and Sex differences in young adults hospitalized with Acute myocardial infarction. Circulation. 2019;139(8):1047–56.CrossRefPubMedPubMedCentral
21.
go back to reference Lee CH, Fang CC, Tsai LM, Gan ST, Lin SH, Li YH. Patterns of Acute myocardial infarction in Taiwan from 2009 to 2015. Am J Cardiol. 2018;122(12):1996–2004.CrossRefPubMed Lee CH, Fang CC, Tsai LM, Gan ST, Lin SH, Li YH. Patterns of Acute myocardial infarction in Taiwan from 2009 to 2015. Am J Cardiol. 2018;122(12):1996–2004.CrossRefPubMed
22.
go back to reference Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC. Jr. Declining severity of myocardial infarction from 1987 to 2002: the atherosclerosis risk in communities (ARIC) Study. Circulation. 2009;119(4):503–14.CrossRefPubMed Myerson M, Coady S, Taylor H, Rosamond WD, Goff DC. Jr. Declining severity of myocardial infarction from 1987 to 2002: the atherosclerosis risk in communities (ARIC) Study. Circulation. 2009;119(4):503–14.CrossRefPubMed
23.
go back to reference Kastrati A, Colleran R, Ndrepepa G. Cardiogenic shock: how long does the storm last? J Am Coll Cardiol. 2016;67(7):748–50.CrossRefPubMed Kastrati A, Colleran R, Ndrepepa G. Cardiogenic shock: how long does the storm last? J Am Coll Cardiol. 2016;67(7):748–50.CrossRefPubMed
24.
go back to reference Mahmoud AN, Elgendy IY, Mojadidi MK, Wayangankar SA, Bavry AA, Anderson RD et al. Prevalence, causes, and predictors of 30-Day readmissions following hospitalization with Acute Myocardial Infarction Complicated by cardiogenic shock: findings from the 2013–2014 National readmissions Database. J Am Heart Assoc. 2018;7(6). Mahmoud AN, Elgendy IY, Mojadidi MK, Wayangankar SA, Bavry AA, Anderson RD et al. Prevalence, causes, and predictors of 30-Day readmissions following hospitalization with Acute Myocardial Infarction Complicated by cardiogenic shock: findings from the 2013–2014 National readmissions Database. J Am Heart Assoc. 2018;7(6).
25.
go back to reference McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.CrossRefPubMed McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.CrossRefPubMed
27.
go back to reference Zorowitz RD, ICU-Acquired Weakness. A Rehabilitation perspective of diagnosis, treatment, and Functional Management. Chest. 2016;150(4):966–71.CrossRefPubMed Zorowitz RD, ICU-Acquired Weakness. A Rehabilitation perspective of diagnosis, treatment, and Functional Management. Chest. 2016;150(4):966–71.CrossRefPubMed
28.
go back to reference Yonis H, Sørensen KK, Bøggild H, Ringgren KB, Malta Hansen C, Granger CB, et al. Long-term quality of Life after out-of-hospital cardiac arrest. JAMA Cardiol. 2023;8(11):1022–30.CrossRefPubMed Yonis H, Sørensen KK, Bøggild H, Ringgren KB, Malta Hansen C, Granger CB, et al. Long-term quality of Life after out-of-hospital cardiac arrest. JAMA Cardiol. 2023;8(11):1022–30.CrossRefPubMed
29.
go back to reference Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246–56.CrossRefPubMed Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246–56.CrossRefPubMed
30.
go back to reference Chien SC, Lan WR, Wu SH, Chien CY, Chien YS, Lo CI, et al. Application and comparison of different prognostic Scoring systems in patients who underwent cardiologist-managed percutaneous cardiopulmonary support. Acta Cardiol Sin. 2020;36(4):326–34.PubMedPubMedCentral Chien SC, Lan WR, Wu SH, Chien CY, Chien YS, Lo CI, et al. Application and comparison of different prognostic Scoring systems in patients who underwent cardiologist-managed percutaneous cardiopulmonary support. Acta Cardiol Sin. 2020;36(4):326–34.PubMedPubMedCentral
31.
go back to reference Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive care med. 2016;42(3):370–8.CrossRefPubMed Muller G, Flecher E, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, et al. The ENCOURAGE mortality risk score and analysis of long-term outcomes after VA-ECMO for acute myocardial infarction with cardiogenic shock. Intensive care med. 2016;42(3):370–8.CrossRefPubMed
32.
go back to reference Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noè A, Carr D, et al. Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. ESC Heart Fail. 2018;5(2):327–36.CrossRefPubMed Pascual-Figal D, Wachter R, Senni M, Belohlavek J, Noè A, Carr D, et al. Rationale and design of TRANSITION: a randomized trial of pre-discharge vs. post-discharge initiation of sacubitril/valsartan. ESC Heart Fail. 2018;5(2):327–36.CrossRefPubMed
33.
go back to reference Tromp J, Ponikowski P, Salsali A, Angermann CE, Biegus J, Blatchford J, et al. Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial. Eur J Heart Fail. 2021;23(5):826–34.CrossRefPubMed Tromp J, Ponikowski P, Salsali A, Angermann CE, Biegus J, Blatchford J, et al. Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial. Eur J Heart Fail. 2021;23(5):826–34.CrossRefPubMed
34.
go back to reference Huang YT, Wei T, Huang YL, Wu YP, Chan KA. Validation of diagnosis codes in healthcare databases in Taiwan, a literature review. Pharmacoepidemiol Drug Saf. 2023;32(7):795–811.CrossRefPubMed Huang YT, Wei T, Huang YL, Wu YP, Chan KA. Validation of diagnosis codes in healthcare databases in Taiwan, a literature review. Pharmacoepidemiol Drug Saf. 2023;32(7):795–811.CrossRefPubMed
35.
go back to reference Kim HK, Tantry US, Smith SC Jr., Jeong MH, Park SJ, Kim MH, et al. The east Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021;121(4):422–32.CrossRefPubMed Kim HK, Tantry US, Smith SC Jr., Jeong MH, Park SJ, Kim MH, et al. The east Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease. Thromb Haemost. 2021;121(4):422–32.CrossRefPubMed
Metadata
Title
Comparison of the prognosis among in-hospital survivors of cardiogenic shock based on etiology: AMI and Non-AMI
Authors
Shih-Chieh Chien
Cheng-An Wang
Hung-Yi Liu
Chao-Feng Lin
Chun-Yao Huang
Li-Nien Chien
Publication date
01-12-2024
Publisher
Springer International Publishing
Published in
Annals of Intensive Care / Issue 1/2024
Electronic ISSN: 2110-5820
DOI
https://doi.org/10.1186/s13613-024-01305-2

Other articles of this Issue 1/2024

Annals of Intensive Care 1/2024 Go to the issue